Brand / product

Hepaldi

Sofosbuvir · 400 mg

₨ Official source-observed price PKR 11,392.70 4x7's

PKR 406.88 / tablet

✓ Official DRAP price source observed · Source checked 2026-09-25

Price Intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →

This brandPKR 406.88/ tablet

Price position6% below medianvs like-for-like peer median

Peer comparators59current-price listings

🔒

MedInfoBase Pharma Pro

Unlock the full competitive price benchmark

See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.

Rank & percentilePeer medianFull competitor listPortfolio intelligence

View Price Intelligence PRO

Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.

Product details

Generic: Sofosbuvir
Therapeutic area: Anti-infectives
Drug class: Antivirals
ATC: J05
Strength: 400 mg
Dosage form: Tablet
Pack: 4x7's
Registration no.: 080797
Price record verified: 2026-08-24
Latest DRAP source check: 2026-09-25 03:02

Manufacturer

Scotmann Pharmaceuticals

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →

Price movement

Official price over time

PKR 10,856.40 to 11,392.70 (+4.9%) between 1 Sep 2025 and 20 Aug 2026 · 2 official price records · pack 4x7's

Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.

Cite this price history

MedInfoBase. Hepaldi 400 mg, 4x7's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/hepaldi-400-mg-080797-4x7s-scotmann-pharmaceuticals/ (accessed 25 September 2026).

Traceability

Official price history

Amount	Effective from	Verified	Source	Status
PKR 11,392.70	2026-08-20	2026-08-24	DRAP PharmaPrice Index	Current
PKR 10,856.40	2025-09-01	2026-08-09	DRAP PharmaPrice Index	Historical

Same generic

Other listed brands

ABRIVA 400 mgCCL Pharmaceuticals (Pvt.) Limited · PKR 12,119.20 Basovir 400 mgHIGH-Q Pharmaceuticals · PKR 11,708.49 C-OFF 400 mgAtco Laboratories Limited · PKR 11,948.35 Cell 400 mgWerrick Pharmaceuticals · PKR 10,835.76 CHC Plus-400mg 400 mgGenome Pharmaceuticals (Pvt.) Ltd. · PKR 19,413.15 CHC-400 400 mgGenome Pharmaceuticals (Pvt.) Ltd. · PKR 11,391.64 Cure-C 400 mgGlobal Pharmaceuticals (Pvt.) Ltd. · PKR 9,352.82 Fosbir 90 mgNovaMed Pharmaceuticals(Pvt.)Ltd · PKR 49,634.86

Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.

Cite this record

Medicine record · DRAP registration 080797

MedInfoBase. (2026). Hepaldi 400 mg Tablet (4x7's), Scotmann Pharmaceuticals — registration and price record [Data set]. MedInfoBase. Retrieved September 25, 2026, from https://medinfobase.com/brand/hepaldi-400-mg-080797-4x7s-scotmann-pharmaceuticals/ Data observed 24 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 080797.

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.